institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

HHS cancels nearly $600 million Moderna contract on vaccines for flu pandemics

  • On May 28, 2025, the U.S. government terminated a $766 million agreement with Moderna to support the final-stage development of its bird flu vaccine.
  • The contract, awarded in July 2024 and January 2025, was terminated due to safety, scientific, and ethical concerns raised by the administration.
  • Moderna had reported positive interim results from a Phase 1/2 trial involving about 300 adults, showing a robust immune response and acceptable safety profile.
  • Moderna’s CEO Stéphane Bancel expressed satisfaction with the favorable immune response and positive safety outcomes seen in the interim Phase 1/2 trial data, and committed to investigating other options to continue the vaccine development despite funding uncertainties.
  • The contract cancellation creates uncertainty for Moderna's vaccine development, reflecting ongoing debate over mRNA vaccine safety and the risk of future bird flu pandemics.
Insights by Ground AI
Does this summary seem wrong?

339 Articles

All
Left
49
Center
162
Right
38
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 65% of the sources are Center
65% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

KGW 8 broke the news in Portland, United States on Wednesday, May 28, 2025.
Sources are mostly out of (0)